Skip to main content
Premium Trial:

Request an Annual Quote

Shares of Nanosphere Rebound

NEW YORK (GenomeWeb News) – Shares of molecular diagnostics firm Nanosphere rebounded today, after falling sharply earlier in the week.
 
Shares of the Northbrook, Ill.-based firm were up 26 percent at $6 in late Friday afternoon trade on the Nasdaq.
 
On Monday, Nanosphere’s stock tumbled 35 percent to close at $4.26, even though it reported no news and it didn’t make any regulatory filings that would account for such a sell-off. Some investors have speculated that hedge funds may have been selling the firm’s stock to fund redemption requests from investors.
 

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.